LIDDS Past Earnings Performance
Past criteria checks 0/6
LIDDS's earnings have been declining at an average annual rate of -12%, while the Biotechs industry saw earnings declining at 1.4% annually. Revenues have been declining at an average rate of 31.1% per year.
Key information
-12.0%
Earnings growth rate
2.7%
EPS growth rate
Biotechs Industry Growth | 0.7% |
Revenue growth rate | -31.1% |
Return on equity | -289.3% |
Net Margin | n/a |
Next Earnings Update | 06 May 2024 |
Recent past performance updates
Recent updates
Here's Why We're Watching LIDDS' (STO:LIDDS) Cash Burn Situation
May 26Here's Why We're Watching LIDDS' (STO:LIDDS) Cash Burn Situation
Dec 15Will LIDDS (STO:LIDDS) Spend Its Cash Wisely?
Jul 19Here's Why We're Not Too Worried About LIDDS' (STO:LIDDS) Cash Burn Situation
Mar 08We're Not Very Worried About LIDDS' (STO:LIDDS) Cash Burn Rate
Nov 23Revenue & Expenses BreakdownBeta
How LIDDS makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 0 | -40 | 11 | 0 |
30 Sep 23 | 0 | -31 | 14 | 0 |
30 Jun 23 | 1 | -34 | 16 | 0 |
31 Mar 23 | 1 | -37 | 16 | 0 |
31 Dec 22 | 2 | -37 | 16 | 0 |
30 Sep 22 | 4 | -37 | 15 | 0 |
30 Jun 22 | 4 | -36 | 14 | 0 |
31 Mar 22 | 4 | -36 | 13 | 0 |
31 Dec 21 | 4 | -37 | 11 | 0 |
30 Sep 21 | 2 | -41 | 10 | 0 |
30 Jun 21 | 1 | -40 | 10 | 0 |
31 Mar 21 | 1 | -35 | 8 | 0 |
31 Dec 20 | 0 | -32 | 7 | 0 |
30 Sep 20 | 0 | -28 | -12 | 0 |
30 Jun 20 | 0 | -29 | -6 | 0 |
31 Mar 20 | 0 | -32 | 1 | 0 |
31 Dec 19 | 0 | -31 | 7 | 0 |
30 Sep 19 | 0 | -28 | 24 | 0 |
30 Jun 19 | 8 | -15 | 14 | 0 |
31 Mar 19 | 8 | -9 | 8 | 0 |
31 Dec 18 | 9 | -21 | 4 | 0 |
30 Sep 18 | 8 | -1 | 1 | 0 |
30 Jun 18 | 1 | -8 | 6 | 0 |
31 Mar 18 | 1 | -7 | 3 | 0 |
31 Dec 17 | 1 | -7 | 3 | 0 |
30 Sep 17 | 1 | -7 | 3 | 0 |
30 Jun 17 | 0 | -7 | 1 | 0 |
31 Mar 17 | 0 | -7 | 3 | 0 |
31 Dec 16 | 0 | -7 | 3 | 0 |
30 Sep 16 | 0 | -6 | 6 | 0 |
30 Jun 16 | 0 | -6 | 6 | 0 |
31 Mar 16 | 0 | -7 | 7 | 0 |
31 Dec 15 | 0 | -8 | 8 | 0 |
30 Sep 15 | 0 | -8 | 8 | 0 |
30 Jun 15 | 0 | -8 | 8 | 0 |
31 Mar 15 | 0 | -8 | 8 | 0 |
31 Dec 14 | 0 | -7 | 7 | 0 |
30 Sep 14 | 0 | -6 | 6 | 0 |
30 Jun 14 | 0 | -6 | 6 | 0 |
31 Mar 14 | 0 | -4 | 4 | 0 |
31 Dec 13 | 0 | -4 | 4 | 0 |
Quality Earnings: LIDDS is currently unprofitable.
Growing Profit Margin: LIDDS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: LIDDS is unprofitable, and losses have increased over the past 5 years at a rate of 12% per year.
Accelerating Growth: Unable to compare LIDDS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: LIDDS is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-14.4%).
Return on Equity
High ROE: LIDDS has a negative Return on Equity (-289.27%), as it is currently unprofitable.